AstraZeneca is accelerating a project on the research, production, and technology transfer of pharmaceutical products in Vietnam worth $90 million and is selecting a partner to transfer its Covid-19 vaccine technology to Vietnam, in order to accompany and support the country in becoming a leading pharmaceutical center of the region.

In order to ensure the quality of imported pharmaceuticals, the General Department of Vietnam Customs requires that, from August 1, enterprises present the original power of attorney, storage permit, and product test sheets when importing shipments of drugs and medicinal ingredients.